Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1981 Jan;11(1):69–72. doi: 10.1111/j.1365-2125.1981.tb01104.x

Ibopamine (SB 7505) in normal subjects and in chronic renal failure: a preliminary report.

S Stefoni, L Colì, G Mosconi, R Prandini
PMCID: PMC1401702  PMID: 7213512

Abstract

1 Pharmacological and experimental studies have shown that ibopamine (SB 7505, di-isobutyric ester of N-methyldopamine) is capable of increasing renal blood flow, diuresis, urinary sodium, potassium and creatinine excretion. 2 SB 7505 was given to twelve volunteer patients, six of whom had normal renal function and six with various degrees of chronic renal impairment. 3 In both groups the drug yielded a prompt increase in urinary excretion of water, sodium and potassium, while creatinine clearance was also seen to increase. 4 Heart rate and arterial pressure were unaffected by SB 7505 in all patients. 5 Results seen encouraging and call for further study on the proper use of the drug in clinical nephrology.

Full text

PDF
69

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baglin A., Goupil A., Domart M., Fritel D. Effets de la dopamine sur l'excrétion rénale dans i'insuffisance rénale chronique. Nouv Presse Med. 1979 May 19;8(22):1821–1825. [PubMed] [Google Scholar]
  2. Dei Cas L., Manca C., Vasini G., Mansour M., Bernardini B., Visioli O. Non-invasive evaluation of left ventricular function through systolic time intervals following oral administration of SB 7505 in man. Arzneimittelforschung. 1980;30(3):498–500. [PubMed] [Google Scholar]
  3. Goldberg L. I. Dopamine--clinical uses of an endogenous catecholamine. N Engl J Med. 1974 Oct 3;291(14):707–710. doi: 10.1056/NEJM197410032911405. [DOI] [PubMed] [Google Scholar]
  4. PROCKOP D. J., DAVIDSON W. D. A STUDY OF URINARY AND SERUM LYSOZYME IN PATIENTS WITH RENAL DISEASE. N Engl J Med. 1964 Feb 6;270:269–274. doi: 10.1056/NEJM196402062700602. [DOI] [PubMed] [Google Scholar]
  5. Persijn J. P., van der Slik W. A new method for the determination of gamma-glutamyltransferase in serum. J Clin Chem Clin Biochem. 1976 Sep;14(9):421–427. doi: 10.1515/cclm.1976.14.1-12.421. [DOI] [PubMed] [Google Scholar]
  6. Stefoni S., Prandini R., Campieri C., Fatone F., Borgnino L. C., Colì L. Determinazione nelle urine dell'enzima gamma-glutamiltranspeptidasi (gamma GT). Utilità in nefrologia. Minerva Nefrol. 1979 Oct-Dec;26(4):513–516. [PubMed] [Google Scholar]
  7. Wilson J. R. Dopamine in the hepatorenal syndrome. JAMA. 1977 Dec 19;238(25):2719–2720. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES